Literature DB >> 8082666

Parameters influencing SPET regional brain uptake of technetium-99m hexamethylpropylene amine oxine measured by calibrated point sources as an external standard.

R A Dierckx1, A Dobbeleir, M Maes, B A Pickut, A Vervaet, P P De Deyn.   

Abstract

Using calibrated point sources as an external standard to convert single-photon emission tomography (SPET) brain counts into absolute values of regional brain uptake (rBU) of technetium-99m hexamethylpropylene amine oxime (HMPAO), the relative contribution of different parameters to interindividual variability of cerebellar rBU was examined in 33 healthy volunteers. Stepwise regression analysis identified body surface as the most important factor underlying interindividual variability (P < 0.001), when compared with brain volume. In the normal volunteer population presented, age decrement of rBU corrected for body surface and brain volume equalled 60.5-0.20 x age. Based on the data of eight normal volunteers, including four test-retest studies with heart rate (HR) differences greater than 5 units and four test-stress studies with doubling of heart rate after bicycle exercise, influence of heart rate may be expressed by the equation delta rBU = 0.35 delta HR. Clinically, estimation of the relative influence of different factors allows normalization and extension of the applicability of the rBU quantification method used from longitudinal studies to group comparisons. Interestingly, results of the Daily Stress Inventory Scale and a subjective rating scale suggest the absence of a significant influence of minor stress on rBU. When using one vial per patient, chromatography may be omitted in clinical routine practice and lipophilicity may be estimated as 90% of the injected dose, if administered within 10 min after preparation. Finally, sensitivity of the quantification method was tested in eight volunteers using acetazolamide brain activation and showed a mean increase in cerebellar rBU of 30.2%, varying between 14.1% and 75.9%.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082666     DOI: 10.1007/bf00173038

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  26 in total

Review 1.  Brain single photon emission computed tomography: newer activation and intervention studies.

Authors:  R S Tikofsky; R S Hellman
Journal:  Semin Nucl Med       Date:  1991-01       Impact factor: 4.446

2.  A comparison of three methods to determine the radiochemical purity of 99Tcm-hexamethylpropylene amine oxime (99Tcm-HMPAO).

Authors:  G Mah; R M Reilly; G L Wong; S Houle
Journal:  Nucl Med Commun       Date:  1989-10       Impact factor: 1.690

3.  [133Xe-DSPECT: significance of the cerebrovascular reserve capacity for the diagnosis and therapy of chronic cerebral ischemia].

Authors:  G Leinsinger; P Schmiedek; T Kreisig; K Einhäupl; W Bauer; E Moser
Journal:  Nuklearmedizin       Date:  1988-08       Impact factor: 1.379

4.  The retention of [99mTc]-d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis.

Authors:  N A Lassen; A R Andersen; L Friberg; O B Paulson
Journal:  J Cereb Blood Flow Metab       Date:  1988-12       Impact factor: 6.200

5.  Hyperfixation of HMPAO in subacute ischemic stroke leading to spuriously high estimates of cerebral blood flow by SPECT.

Authors:  B Sperling; N A Lassen
Journal:  Stroke       Date:  1993-02       Impact factor: 7.914

6.  Tc-99m HMPAO tomography using a three-headed SPECT system equipped with lead fanbeam collimators.

Authors:  R Dierckx; A Dobbeleir; J J Martin; P P Deyn
Journal:  Clin Nucl Med       Date:  1993-06       Impact factor: 7.794

7.  Quantification of regional cerebral blood flow (rCBF) using 99Tcm-HMPAO and SPECT: choice of the reference region.

Authors:  G M Syed; S Eagger; B K Toone; R Levy; J J Barrett
Journal:  Nucl Med Commun       Date:  1992-11       Impact factor: 1.690

8.  Kinetic analysis of technetium-99m d,1-HM-PAO decomposition in aqueous media.

Authors:  J C Hung; M Corlija; W A Volkert; R A Holmes
Journal:  J Nucl Med       Date:  1988-09       Impact factor: 10.057

9.  The behavior of 99mTc-hexamethylpropyleneamineoxime (99mTc-HMPAO) in blood and brain.

Authors:  K Nakamura; Y Tukatani; A Kubo; S Hashimoto; Y Terayama; T Amano; F Goto
Journal:  Eur J Nucl Med       Date:  1989

10.  Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion.

Authors:  R D Neirinckx; L R Canning; I M Piper; D P Nowotnik; R D Pickett; R A Holmes; W A Volkert; A M Forster; P S Weisner; J A Marriott
Journal:  J Nucl Med       Date:  1987-02       Impact factor: 10.057

View more
  1 in total

1.  Technetium-99m HMPAO SPET in acute supratentorial ischaemic infarction, expressing deficits as millilitre of zero perfusion.

Authors:  R A Dierckx; A Dobbeleir; B A Pickut; L Timmermans; I Dierckx; A Vervaet; J Vandevivere; W Deberdt; P P De Deyn
Journal:  Eur J Nucl Med       Date:  1995-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.